Bleeding and spotting with the levonorgestrel 13.5mg intrauterine system: The impact of insertion timing
Contraception Mar 07, 2019
Shimoni N, et al. - In this observational study, researchers investigated how early vs late menstrual cycle insertion influence bleeding/spotting in the 90 days following levonorgestrel (LNG) 13.5 mg intrauterine system (IUS) insertion. Participants (n=125) received a LNG 13.5 mg IUS and provided 90 days of bleeding/spotting data. The 90-day dichotomous analysis showed that the early and late insertion groups were not different regarding the number of days of bleeding/spotting, bleeding, or spotting. However, they noted decreased 30-day bleeding in correlation with early cycle insertion and recent hormonal contraceptive use. These findings support insertion of LNG 13.5 mg IUS throughout the menstrual cycle with small differences in bleeding patterns in the 30 but not the 90 days following insertion.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries